RBC Life Science and Technology Fund (NEO:RLST)

Assets	29.42M
Expense Ratio	0.95%
PE Ratio	n/a
Forward PE	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	58
Open	29.50
Previous Close	29.64
Day's Range	29.50 - 29.78
52-Week Low	23.06
52-Week High	32.43
Beta	0.31
Holdings	n/a
Inception Date	Sep 18, 2024

About RLST

RBC Life Science and Technology Fund is an open-ended equity mutual fund launched and managed by RBC Global Asset Management Inc. The fund invests in the public equity markets of the United States. It invests in stocks of companies operating in life science and technology sectors. The fund employs combination of fundamental and quantitative analysis along with a bottom-up stock picking approach focusing on companies with strong management, focused business models, competitive advantage, and leading edge technologies with defendable intellectual property. It benchmarks the performance of its portfolio against the 50% S&P 500 Health Care Index and 50% S&P 500 Information Technology Index. The fund was formerly known as Royal Life Science & Technology Fund. RBC Life Science and Technology Fund was formed in June 30, 1995 and is domiciled in Canada.

• Asset Class: Equity
• Category: US Equity
• Region: North America
• Stock Exchange: Cboe Canada
• Ticker Symbol: RLST
• Provider: RBC

Performance

RLST had a total return of 13.20% in the past year, including dividends. Since the fund's inception, the average annual return has been 20.31%.

Data Sources: Twelve Data and Finnhub

Historical data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Nov 12, 2026

Data Sources Report a data error